Coronavirus COVID-19 Daily Update 10th April 2020

Coronavirus COVID-19 Daily Update 10th April 2020

If you are a healthcare professional, please join the discussion on these latest COVID-19 cases on MedShr:

Please post any COVID-19 cases, images or learning points from your clinical practice on MedShr - share key knowledge and experience with a global network of doctors to help improve patient care. Include #COVID19 in your case title.


Please email COVID@medshr.net if you have any data, publications or information you would like to share.

Global Impact of COVID-19 to Date

As of 10th April 10:00 (GMT)

COVID-19 Cumulative Global Cases

As of 9th April 09:00 (GMT)

COVID-19 Global Active Cases Map

As of 10th April 10:00 GMT

Total UK COVID-19 Cases

As of 9th April

NB: Public Health England has now moved to a different reporting time for UK COVID-19 fatalities, as family consent is now needed to release mortality statistics. Hence the reported figures may not actually be the deaths that have taken place over the past 24 hours, meaning caution needs to be exercised when comparing figures from one day to the next.

COVID-19 Cumulative UK Cases

As of 9th April

COVID-19 Daily UK Cases

As of 9th April

COVID-19 outbreaks in Arab countries

As of 2nd April 2020

Focus of Covid-19 deaths has switched from Asia to Europe - and now the US

As of 9th April 2020

Coronavirus case trajectories

As of 10th April 2020

Coronavirus death trajectories

As of 10th April 2020

Infection & Fatality Rates by Country

As of 10th April 2020

COVID-19 Key Data

As of 31st March 2020

Coronavirus deaths by age

As of 27th March 2020

Source: BBC


Remdesivir (solid) and Chloroquine (dotted) test results

4th February 2020

Source: J P Morgan

Treatment results of patients with COVID-19

March 2020

Source: J P Morgan

Excerpt from J P Morgan: Vaccine and anti-viral update; the Chloroquine controversy; Convalescent plasma (Last update 4th April 2020)

Critique of Study by Gautret el al, March 2020: Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial

  • non-randomized trial with only 36 patients, and had no discussion of outcomes

  • excluded 6 recipients that were not discussed, some of whom of required ventilation and/or died

  • started out with higher viral loads in the control group than in the infected patients, which could explain why the control group showed higher infected rates at the conclusion of the study

  • imputed more than 1/3 of the control group virus tests rather than measuring them

  • sourced its treatment group (unlike the control group) from a single medical center


Latest Developments


Africa


Asia


Middle East


Europe


United Kingdom


USA


Coronavirus situation in the US

As of 10th April 2020

Latest COVID-19 Publications

Some key recent publications to be aware of:

School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review

Prof Russell M Viner, PhD, Simon J Russell, PhD, Helen Croker, PhD, Jessica Packer, MEpi, Joseph Ward, MBBS Claire Stansfield, PhD et al.

Published: April 06, 2020

This review identifies studies from SARS outbreak and COVID-19 outbreak.  The overall findings were of a lack of data on the benefit of school closures on transmission of coronaviruses.  The authors identify that the majority of data suggesting a benefit of school closures in outbreak control is derived from influenza pandemics, which have very different transmission characteristics.


Two Cases of COVID-19 Related Cardiomyopathy in Pregnancy

Published 3rd April 2020

American Journal of Obstetrics & Gynecology MFM

Featured in MedShr Open Article: COVID-19 in Pregnancy

Report on 2 cases of cardiomyopathy in COVID-19 pregnant patients. Although viral myocarditis and cardiomyopathy have been reported in non-pregnant COVID-19 patients, it is not clear if this group of patients are at higher risk.

Diagnostic Value and Dynamic Variance of Serum Antibody in Coronavirus Disease 2019

Published 3rd April 2020 (online ahead of print)

International Journal of Infectious Diseases

Investigation on the diagnostic value of serological test and dynamic variance of serum antibody in COVID-19. Concluded that a viral serological test is an effective diagnostic means for SARS-CoV-2 infection. The positive rate and titer variance of IgG are higher than that of IgM in COVID-19.


Comments

Sign in or Register to comment

Matching media queries: